Mail

UK markets closed

FTSE 100
8,139.83
+60.97(+0.75%)
FTSE 250
19,824.16
+222.18(+1.13%)
AIM
755.28
+2.16(+0.29%)
GBP/EUR
1.1679
+0.0022(+0.19%)
GBP/USD
1.2494
-0.0017(-0.13%)
Bitcoin GBP
51,055.91
-584.10(-1.13%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Oscar Health, Inc. (OSCR)

NYSE - NYSE Delayed price. Currency in USD

Add to watchlist

17.56

-0.33

(-1.84%)

At close: 04:00PM EDT

17.50

-0.06

(-0.34%)

After hours:

07:53PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	4.11B
Enterprise value	2.54B
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.68
Price/book (mrq)	5.11
Enterprise value/revenue	0.43
Enterprise value/EBITDA	N/A

Trading information

Stock price history

Beta (5Y monthly)	1.78
52-week change ³	165.82%
S&P500 52-week change ³	21.08%
52-week high ³	18.55
52-week low ³	4.72
50-day moving average ³	15.30
200-day moving average ³	9.78

Share statistics

Avg vol (3-month) ³	3.13M
Avg vol (10-day) ³	2.95M
Shares outstanding ⁵	194.21M
Implied shares outstanding ⁶	229.73M
Float ⁸	171.1M
% held by insiders ¹	1.72%
% held by institutions ¹	80.56%
Shares short (15 Apr 2024) ⁴	7.66M
Short ratio (15 Apr 2024) ⁴	3.28
Short % of float (15 Apr 2024) ⁴	4.67%
Short % of shares outstanding (15 Apr 2024) ⁴	3.33%
Shares short (prior month 15 Mar 2024) ⁴	6.31M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	-4.62%
Operating margin (ttm)	-10.20%

Management effectiveness

Return on assets (ttm)	-3.62%
Return on equity (ttm)	-31.86%

Income statement

Revenue (ttm)	5.86B
Revenue per share (ttm)	26.44
Quarterly revenue growth (yoy)	41.80%
Gross profit (ttm)	N/A
EBITDA	-204.92M
Net income avi to common (ttm)	-270.73M
Diluted EPS (ttm)	-1.22
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	2.56B
Total cash per share (mrq)	11.16
Total debt (mrq)	379.76M
Total debt/equity (mrq)	47.11%
Current ratio (mrq)	1.26
Book value per share (mrq)	3.51

Cash flow statement

Operating cash flow (ttm)	-272.16M
Levered free cash flow (ttm)	546.01M